Similar articles

• Assessment of daily insulin requirements in diabetics with an artificial endocrine pancreas.

  Lambert AE, Buysschaert M, Lambotte L. Lambert AE, et al. Horm Metab Res Suppl. 1979;(8):120-7. Horm Metab Res Suppl. 1979. PMID: 395067 No abstract available.
• The artificial beta cell (Biostator) in the adjustment of instable diabetics--results after 20 months.

  Beyer J, Wolf E, Cordes U, Hassingen W. Beyer J, et al. Horm Metab Res Suppl. 1979;(8):127-31. Horm Metab Res Suppl. 1979. PMID: 395068
• Use of an artificial beta cell in surgery.

  Horwitz DL, Schwartz SS. Horwitz DL, et al. Horm Metab Res Suppl. 1979;(8):156-8. Horm Metab Res Suppl. 1979. PMID: 395072
• [The artificial endocrine pancreas in clinical medicine and in research].

  Pfeiffer EF, Beischer W, Thum C, Clemens AH. Pfeiffer EF, et al. Journ Annu Diabetol Hotel Dieu. 1976 May:279-96. Journ Annu Diabetol Hotel Dieu. 1976. PMID: 796524 Review. French. No abstract available.
• Continuous subcutaneous insulin infusion: a developing tool in diabetes research.

  Pickup JC, Keen H. Pickup JC, et al. Diabetologia. 1980 Jan;18(1):1-4. doi: 10.1007/BF01228294. Diabetologia. 1980. PMID: 6988262 Review. No abstract available.